The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Alie Rezaie, MD | Credit: Cedars-Sinai
Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows

July 22nd 2024

An analysis using records from 40 million US patients highlights the surge in new GLP-1 receptor agonist use, with semaglutide dominating new prescriptions since 2020.

Alex Henney, MBChB | Credit: Alex Henney on LinkedIn
Hyperandrogenism Linked to Increased Risk of MASLD in PCOS

July 17th 2024

FDA Issues CRL to Once-Weekly Insulin Icodec | Image Credit: US Food and Drug Administration
FDA Issues Complete Response Letter for Once-Weekly Insulin Icodec

July 11th 2024

Brendon Neuen, MBBS, PhD | Credit:
SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes

July 9th 2024

Nicholas Stucky, MD, PhD | Credit: LinkedIn
Tirzepatide Bests Semaglutide in Real-World Weight Loss Analysis

July 8th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.